Drug delivery method via oral mucosal tissues (IPO, 1994)

Targeted drug platform for treatment of autoimmune diseases

Detection system for biological compounds
(acquired by Invitrogen, 2003)

Identification of optimal antisense targets on genes
(acquired by Genta, 2003)

Ultrasound contrast agents and drug delivery systems (IPO, 1995)